Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Impact and Prevalence of Physical and Verbal Violence Toward Healthcare Workers.

Rosenthal LJ, Byerly A, Taylor AD, Martinovich Z.

Psychosomatics. 2018 Nov;59(6):584-590. doi: 10.1016/j.psym.2018.04.007. Epub 2018 May 9.

PMID:
29909013
2.

Salaries in Psychosomatic Medicine: A Cross-Sectional Survey of Practicing Physicians.

Rosenthal LJ, Sabuco JJ.

Psychosomatics. 2017 Jan - Feb;58(1):92-94. doi: 10.1016/j.psym.2016.07.003. Epub 2016 Jul 18. No abstract available.

PMID:
28010751
3.

Agitation, Delirium, and Cognitive Outcomes in Intracerebral Hemorrhage.

Rosenthal LJ, Francis BA, Beaumont JL, Cella D, Berman MD, Maas MB, Liotta EM, Askew R, Naidech AM.

Psychosomatics. 2017 Jan - Feb;58(1):19-27. doi: 10.1016/j.psym.2016.07.004. Epub 2016 Aug 5.

4.

Acute traumatic and depressive symptoms in family members of hospitalized individuals with delirium.

Lloyd RB, Rosenthal LJ.

Int J Psychiatry Med. 2015;50(2):191-202. doi: 10.1177/0091217415605033. Epub 2015 Sep 3.

PMID:
26338657
5.

Parameters of consultee satisfaction with inpatient academic psychiatric consultation services: a multicenter study.

Lavakumar M, Gastelum ED, Choo TH, Gerkin JS, Kahn D, Lee S, Nicolson SE, Rosenthal LJ, Schwartz AC, Tobin MB, Wharton RN, Shapiro PA.

Psychosomatics. 2015 May-Jun;56(3):262-7. doi: 10.1016/j.psym.2015.02.004. Epub 2015 Feb 16.

PMID:
25975859
6.

When hawks attack: animal-borne video studies of goshawk pursuit and prey-evasion strategies.

Kane SA, Fulton AH, Rosenthal LJ.

J Exp Biol. 2015 Jan 15;218(Pt 2):212-22. doi: 10.1242/jeb.108597.

7.

Electroconvulsive therapy in a patient with catatonia and an intracranial arachnoid cyst.

Kastenholz KJ, Rosenthal LJ, Dinwiddie SH.

J ECT. 2014 Dec;30(4):e53-4. doi: 10.1097/YCT.0000000000000182. No abstract available.

PMID:
25203289
8.

Serotonin syndrome and stiff-person syndrome: diagnostic challenges in psychosomatic medicine.

Bordelon S, Brett Lloyd R, Rosenthal LJ.

Psychosomatics. 2014 Sep-Oct;55(5):506-11. doi: 10.1016/j.psym.2013.08.001. Epub 2013 Dec 19. No abstract available.

PMID:
24360526
9.

Levamisole: a common cocaine adulterant with life-threatening side effects.

Auffenberg C, Rosenthal LJ, Dresner N.

Psychosomatics. 2013 Nov-Dec;54(6):590-3. doi: 10.1016/j.psym.2013.02.012. Epub 2013 Jun 4. No abstract available.

PMID:
23756121
10.

T3 augmentation in major depressive disorder: safety considerations.

Rosenthal LJ, Goldner WS, O'Reardon JP.

Am J Psychiatry. 2011 Oct;168(10):1035-40. doi: 10.1176/appi.ajp.2011.10030402. No abstract available.

PMID:
21969047
11.

Chronic pain and opiates: balancing pain control and risks in long-term opioid treatment.

Gallagher RM, Rosenthal LJ.

Arch Phys Med Rehabil. 2008 Mar;89(3 Suppl 1):S77-82. doi: 10.1016/j.apmr.2007.12.003. Review.

PMID:
18295655
12.
13.

RNA editing of the human herpesvirus 8 kaposin transcript eliminates its transforming activity and is induced during lytic replication.

Gandy SZ, Linnstaedt SD, Muralidhar S, Cashman KA, Rosenthal LJ, Casey JL.

J Virol. 2007 Dec;81(24):13544-51. Epub 2007 Oct 3.

14.

U94 alters FN1 and ANGPTL4 gene expression and inhibits tumorigenesis of prostate cancer cell line PC3.

Ifon ET, Pang AL, Johnson W, Cashman K, Zimmerman S, Muralidhar S, Chan WY, Casey J, Rosenthal LJ.

Cancer Cell Int. 2005 Jun 22;5:19.

15.
16.

Characterization of the human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) oncogene, kaposin (ORF K12).

Muralidhar S, Veytsmann G, Chandran B, Ablashi D, Doniger J, Rosenthal LJ.

J Clin Virol. 2000 May;16(3):203-13.

PMID:
10738139
17.

Human cytomegalovirus and human herpesvirus 6 genes that transform and transactivate.

Doniger J, Muralidhar S, Rosenthal LJ.

Clin Microbiol Rev. 1999 Jul;12(3):367-82. Review.

18.

Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) transforming gene.

Muralidhar S, Pumfery AM, Hassani M, Sadaie MR, Kishishita M, Brady JN, Doniger J, Medveczky P, Rosenthal LJ.

J Virol. 1998 Jun;72(6):4980-8. Erratum in: J Virol 1999 Mar;73(3):2568.

19.

Cell lines containing and expressing the human herpesvirus 6A ts gene are protected from both H-ras and BPV-1 transformation.

Araujo JC, Doniger J, Stöppler H, Sadaie MR, Rosenthal LJ.

Oncogene. 1997 Feb 27;14(8):937-43.

20.

Human herpesvirus 6 (HHV-6) ORF-1 transactivating gene exhibits malignant transforming activity and its protein binds to p53.

Kashanchi F, Araujo J, Doniger J, Muralidhar S, Hoch R, Khleif S, Mendelson E, Thompson J, Azumi N, Brady JN, Luppi M, Torelli G, Rosenthal LJ.

Oncogene. 1997 Jan 23;14(3):359-67.

21.

Human cytomegalovirus mtrII oncoprotein binds to p53 and down-regulates p53-activated transcription.

Muralidhar S, Doniger J, Mendelson E, Araujo JC, Kashanchi F, Azumi N, Brady JN, Rosenthal LJ.

J Virol. 1996 Dec;70(12):8691-700.

22.

Human herpesvirus 6A ts suppresses both transformation by H-ras and transcription by the H-ras and human immunodeficiency virus type 1 promoters.

Araujo JC, Doniger J, Kashanchi F, Hermonat PL, Thompson J, Rosenthal LJ.

J Virol. 1995 Aug;69(8):4933-40.

23.

Transcriptional activation of minimal HIV-1 promoter by ORF-1 protein expressed from the SalI-L fragment of human herpesvirus 6.

Kashanchi F, Thompson J, Sadaie MR, Doniger J, Duvall J, Brady JN, Rosenthal LJ.

Virology. 1994 May 15;201(1):95-106.

PMID:
8178493
24.

A transforming fragment within the direct repeat region of human herpesvirus type 6 that transactivates HIV-1.

Thompson J, Choudhury S, Kashanchi F, Doniger J, Berneman Z, Frenkel N, Rosenthal LJ.

Oncogene. 1994 Apr;9(4):1167-75.

PMID:
8134119
25.

A 79 amino acid oncogene is responsible for human cytomegalovirus mtrII induced malignant transformation.

Thompson J, Doniger J, Rosenthal LJ.

Arch Virol. 1994;136(1-2):161-72.

PMID:
8002783
26.

Localization and sequence analysis of morphological transforming region III within human cytomegalovirus strain Towne.

Thompson J, Inamdar A, Jahan N, Doniger J, Rosenthal LJ.

Intervirology. 1993;36(3):121-7.

PMID:
8150593
27.

Identification of two promoters within human cytomegalovirus morphologic transforming region II.

Inamdar A, Thompson J, Kashanchi F, Doniger J, Brady JN, Rosenthal LJ.

Intervirology. 1992;34(3):146-53.

PMID:
1338782
28.

Differences in retention and expression of transfected human cytomegalovirus Towne XbaI-E transforming fragment in human cervical and NIH 3T3 lines.

Choudhury S, Woodworth CD, Inamdar A, el-Beik T, DiPaolo JA, Rosenthal LJ.

Intervirology. 1992;33(4):187-96.

PMID:
1326497
29.

Analysis of peripheral blood lymphocytes of AIDS and high-risk patients for human cytomegalovirus transforming DNA sequences.

Razzaque A, Peters SM, Gelmann EP, Sheridan MJ, Rosenthal LJ.

Intervirology. 1991;32(1):10-8.

PMID:
1849876
30.

The human cytomegalovirus mtrII colinear region in strain Tanaka is transformation defective.

Jahan N, Razzaque A, Brady J, Rosenthal LJ.

J Virol. 1989 Jun;63(6):2866-9.

31.

Analysis of human KS biopsies and cloned cell lines for cytomegalovirus, HIV-1, and other selected DNA virus sequences.

Jahan N, Razzaque A, Greenspan J, Conant MA, Josephs SF, Nakamura S, Rosenthal LJ.

AIDS Res Hum Retroviruses. 1989 Apr;5(2):225-31.

PMID:
2540783
32.

Tumor progression mediated by two cooperating DNA segments of human cytomegalovirus.

Jariwalla RJ, Razzaque A, Lawson S, Rosenthal LJ.

J Virol. 1989 Jan;63(1):425-8.

33.

Localization and DNA sequence analysis of the transforming domain (mtrII) of human cytomegalovirus.

Razzaque A, Jahan N, McWeeney D, Jariwalla RJ, Jones C, Brady J, Rosenthal LJ.

Proc Natl Acad Sci U S A. 1988 Aug;85(15):5709-13.

35.

Multiple transforming regions of human cytomegalovirus DNA.

el-Beik T, Razzaque A, Jariwalla R, Cihlar RL, Rosenthal LJ.

J Virol. 1986 Nov;60(2):645-52.

36.

Human cytomegalovirus completely helps adeno-associated virus replication.

McPherson RA, Rosenthal LJ, Rose JA.

Virology. 1985 Nov;147(1):217-22.

PMID:
2998066
37.

Characterization and location of myc homologous sequences in human cytomegalovirus DNA.

Gelmann EP, Clanton DJ, Jariwalla RJ, Rosenthal LJ.

Proc Natl Acad Sci U S A. 1983 Aug;80(16):5107-11.

38.
39.

Isolation of human cytomegalovirus DNA from infected cells.

Rosenthal LJ, Crutchfield DB, Panitz PJ, Clanton DJ.

Intervirology. 1983;19(2):113-20.

PMID:
6305866
40.

Breast abscess: management in subareolar and peripheral disease.

Rosenthal LJ, Greenfield DS, Lesnick GJ.

N Y State J Med. 1981 Feb;81(2):182-3. No abstract available.

PMID:
6936631
41.

Cytomegalovirus replication in primary and passaged human placental cells.

Rosenthal LJ, Panitz PJ, Crutchfield DB, Chou JY.

Intervirology. 1981;16(3):168-75.

PMID:
6277823
42.
43.

Effect of azacytidine on Simian Virus 40 nucleoprotein complexes.

Johnson-Thompson M, Rosenthal LJ.

Antimicrob Agents Chemother. 1979 Nov;16(5):667-73.

44.

Defective virions of human cytomegalovirus.

Ramirez ML, Virmani M, Garon C, Rosenthal LJ.

Virology. 1979 Jul 15;96(1):311-4. No abstract available.

PMID:
223307
45.

Nonoperative management of distal fingertip amputations in children.

Rosenthal LJ, Reiner MA, Bleicher MA.

Pediatrics. 1979 Jul;64(1):1-3. No abstract available.

PMID:
450537
46.

Replication of herpesviruses and latency.

Rosenthal LJ.

Can J Microbiol. 1979 Mar;25(3):239-44. Review. No abstract available.

PMID:
222412
47.

Inhibition of SV40 replication by 5-azacytidine: effect on DNA synthesis and conformation.

Johnson-Thompson M, Rosenthal LJ.

Virology. 1979 Mar;93(2):605-8. No abstract available.

PMID:
88126
48.

Effect of 5-azacytidine on cytoplasmic ribosomal and messenger ribonucleic acids in BSC-1 cells.

Reuveni Y, Rosenthal LJ.

Antimicrob Agents Chemother. 1979 Feb;15(2):235-9.

49.

Effect of azacytidine in SV40-infected BSC-1 cells.

Reuveni Y, Rosenthal LJ.

Intervirology. 1979;11(3):191-5.

PMID:
85613
50.

Supplemental Content

Loading ...
Support Center